CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Roche Holdings, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Roche Holdings, Inc.
1 DNA Way
Phone: 650-225-1000p:650-225-1000 South San Francisco, CA  94080  United States Fax: 650-225-6000f:650-225-6000
This is a Subsidiary, click here for the Parent Company
Business Summary
Roche Holdings, Inc. is engaged in the pharmaceutical and diagnostic businesses. The Company operates in two divisions, Pharmaceuticals and Diagnostics. The Pharmaceuticals division primarily manufactures various medicines for oncology, rheumatoid arthritis, and post-menopausal osteoporosis diseases. This division also develops oral, small molecule therapeutics for the treatment of hepatitis C virus (HCV) infection. The Diagnostics division offers HCV monitoring and HPV testing equipment for the diagnosis of cervical cancer; diagnostic tests for chlamydia/gonorrhea, cytomegalovirus, and HIV; and blood glucose monitoring systems. This division also provides customized automation and workflow solutions for in vitro diagnostics testing in commercial and hospital laboratories

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations

General Information
Fax Number: 650-225-6000


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024